CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Vitalant

Cliff Numark, Senior Vice President and Chief of Marketing

The Resiliency of The Nation's Blood Supply

Cliff Numark

Cliff Numark

Every day in the United States, more than 40,000 blood products – red cells, platelets and plasma – are needed in hospitals, surgical centers and emergency facilities to help save and improve lives. These blood products are collected from generous volunteer donors, but COVID-19 has shifted how blood services organizations, like Vitalant, connect with donors to ensure blood supplies are sufficient every day.


For Vitalant and other blood services organizations, most volunteer blood drive hosts have typically been schools, churches, businesses and other organizations. During the early days of COVID-19, as organizations adjusted to operating remotely, face-to-face blood drives were no longer an option. And few of the organizations still gathering were allowing offsite individuals onto their grounds, including blood center staff.


In the following months, as Americans grew accustomed to masks and more people received vaccines, blood donors slowly returned to donation centers. But donation rates continue to ebb and flow as unpredictably as COVID-19 itself, making it a challenge to maintain a steady supply for healthcare providers. In fact, this past winter, our country experienced historic blood shortages.


“Healthcare organizations and their patients depend on a safe and available blood supply for emergencies, as well as everyday procedures and therapies. Blood donation is often considered to be the ‘backbone’ of our healthcare system”


Even now, blood drives have not returned at the same pace or frequency. While there has been progress with scheduling new blood drives, the number of blood donations given at community blood drives is far below pre-pandemic levels. In 2019, approximately 60 percent of all Vitalant blood donations came from community blood drives; today, only about 50 percent do. This means that for many blood donors, there may no longer be a convenient donation location because of these shifts.


Healthcare organizations and their patients depend on a safe and available blood supply for emergencies, as well as everyday procedures and therapies. Blood donation is often considered to be the “backbone” of our healthcare system. While many healthcare organizations host blood drives, there is also ample opportunity to strengthen the resiliency of the blood supply.


Employer-hosted blood drives are paramount for adding needed capacity to the blood donation pipeline. They can also be a meaningful addition to corporate social responsibility efforts as the “Great Resignation” and pandemic fatigue continues to challenge organizations.


To the extent that companies, places of worships and schools are in person, we need their help more than ever. Unfortunately, many are not gathering the way they did previously . In response to these challenges, and to supplement in person blood drives, Vitalant created Virtual Blood Drives, an online program (vitalant.org/virtualblood-drive) that allows organizations to motivate their employees and supporters to give blood at donation centers or other nearby blood drives. (Organizations outside of Vitalant’s service area can locate their nearest blood center for more information at aabb.org.)


Blood donation arose as a civic duty in the 1940s during WWII. Our nation’s people found a collective cause to rally behind in donating blood plasma for soldiers fighting overseas. It’s that historic American spirit and sense of community that’s needed now to avert shortages and ensure that lifesaving blood is available every day, whenever and wherever it’s needed.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreviewapac.com/leadership-perspective/cliff-numark-nwid-2759.html